← Evidence map

ArticleFrontiers in medicine2021

Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA.

Thomas Drasch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA. | OpenQuestion